RETRACTION: Rectal Misoprostol Versus Intravenous Oxytocin for Prevention of Postpartum Hemorrhage
- PMID: 41358781
- DOI: 10.1002/ijgo.70737
RETRACTION: Rectal Misoprostol Versus Intravenous Oxytocin for Prevention of Postpartum Hemorrhage
Abstract
Nasr A, Shahin AY, Elsamman AM, Zakherah MS, Shaaban OM. Rectal Misoprostol Versus Intravenous Oxytocin for Prevention of Postpartum Hemorrhage. Int J Gynecol Obstet. 2009;105(3): 244-247. https://doi.org/10.1016/j.ijgo.2009.01.018. The above article, published online on 03 June 2015 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Michael Geary; and John Wiley & Sons Ltd. UK. Concerns were raised by a third party that many of the reported p-value results for difference in age, BMI, and weight are incorrect. Additionally, the third party expressed concern that the inconsistent baseline results reported in Table 1 suggest that the study may not be a legitimate randomized controlled trial, as is claimed in the methods section. The authors responded to a request for clarification, but they were unable to provide their raw study data. Their responses to questions regarding their reported statistical results did not allay the concerns of the editorial team and publisher. As a result, the data and conclusions are considered unreliable, and therefore the article must be retracted. Speaking on behalf of the authors, A. Nasr does not agree with the decision to issue an retraction.
© 2025 International Federation of Gynecology and Obstetrics.
Retraction of
-
Rectal misoprostol versus intravenous oxytocin for prevention of postpartum hemorrhage.Int J Gynaecol Obstet. 2009 Jun;105(3):244-7. doi: 10.1016/j.ijgo.2009.01.018. Epub 2009 Feb 26. Int J Gynaecol Obstet. 2009. Retraction in: Int J Gynaecol Obstet. 2026 Feb;172(2):1291. doi: 10.1002/ijgo.70737. PMID: 19249048 Retracted. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
